Let's Talk Quality

Hemish Ilangaratne

“Let’s Talk Quality” is a podcast that seeks to shine a light on quality assurance, a profession that acts as the cornerstone for bringing safer medicine to patients. For life science companies to continue to develop life-saving medicines, a culture of good quality must be driven across the industry, whether that be an early phase gene therapy biotech or a global pharma organisation. This podcast aims to drive that mission forward through inviting industry leaders, experts, and visionaries to share their knowledge, experiences, and strategies for achieving quality excellence. Join us on a journey of discovery as we unravel the importance of quality and its profound impact on businesses and society. Get ready to engage in insightful discussions, gain valuable perspectives, and unlock the secrets to fostering a culture of quality in every aspect of life. Tune in and let’s embark on this exciting quality-driven adventure together.

  1. Oct 6

    Maja Pedersen on AI, Strategic Leadership, and Evolving as a Quality Leader

    Maja Pedersen says following a process is what she does least, and she built a career in Quality because a clear framework gives people room to make pragmatic decisions. Maja Pedersen on AI, Strategic Leadership, and Evolving as a Quality Leader In today's episode, we revisit a conversation with Maja Pedersen from July 2025. Maja is now President and Chief Operating Officer at FUJIFILM Biotechnologies. When we recorded this conversation she was Chief Quality Officer, responsible for six sites with a seventh being built in Japan. I really wanted to bring this conversation back because she moved from a TrackWise rollout in medical devices to leading Quality, IT, digitalization and science across a global CDMO. She is at the forefront of AI adoption, and her approach to Quality leadership is built around people and a pragmatic framework. We talk about: How Maja went from a TrackWise rollout in medical devices to leading a Quality team early in her careerTaking over a Quality team of roughly 30 at Cook Medical and understanding people before trying to be understoodBecoming site head of Quality at Biogen in Hillerød and learning to perform through her teamLeading a global team across six sites, including four in-person meetings a year and meditation at the last leadership summitWhy she wants Quality to move from correction to prediction, and why she recommends putting Quality and IT under one leader Thank you Maja for sharing your journey. Timestamps: (00:00) Quality, IT, digitalization and science under one leader (02:45) Why following a process is what she does least (13:34) Inheriting a team of 30 and presenting yourself as a human being (21:56) Moving from tactical to strategic thinking (27:32) Too loud about AI, and how IT landed on her desk (33:06) A global team that meets four times a year and meditates together (38:51) At least an hour and a half of daylight, every day (42:28) Corrections more than preventions: where Quality goes next

    Maja Pedersen on AI, Strategic Leadership, and Evolving as a Quality Leader
  2. Sep 29

    Colleen Walson-Billin on Building a Quality Career Without a Science Degree

    Colleen Walson-Billin was told she was not eligible to progress in Quality without a science degree, and went on to lead a full GxP Quality function at a biologics startup. Colleen Walson-Billin on building a Quality career without a science degree. In today's episode I was joined by Colleen Walson-Billin, Vice President & Head of GxP Quality & Compliance at Jade Biosciences. I wanted to speak to Colleen because her route into Quality started with a business degree and a role as administrative assistant to a director of Quality at Amgen. From there she moved through QA, corporate and international Quality, served twice as chief of staff to the head of Quality, and now leads Quality across GMP, GCP, GLP and pharmacovigilance. We talk about: Starting in Quality as an administrative assistant, and telling her first boss up front that the role was her foot in the doorBeing told she was not eligible to progress without a science degree, and building her technical knowledge on the jobServing twice as chief of staff to the head of Quality, and what she learned at the table with the leadership teamLeaving Amgen for smaller companies, and picking up GCP, GLP and pharmacovigilance for the first timeLeading executive and senior directors, stepping back from being the doer, and positioning Quality as a partner from the start Thank you Colleen for sharing your journey. Timestamps: (00:00) Introduction (00:46) "My foot in the door": business degree to admin assistant (05:02) "You're just not even eligible" (08:51) The advice that made the degree stop mattering (12:34) A career with no plan, built by putting her hand up (19:14) Leaving Amgen for a smaller company (22:01) Employee number 24, and "enough to be dangerous" across GxP (25:14) Why the degree becomes almost irrelevant at 20 years (29:50) Roadblocks, naysayers and the police: old school Quality (35:06) Selling Quality to a room of college students (40:03) Inspired by what she did not want to become

    Colleen Walson-Billin on Building a Quality Career Without a Science Degree
  3. Sep 11

    Isha Patel on the Overnight Career Plan That Took Her from Associate Director to SVP

    Naymisha (Isha) Patel has spent thirty years in Quality and regulatory compliance across pharmaceuticals, biologics, medical devices and combination products. She is now Senior Vice President of Quality at AirNexis Therapeutics, a seven-month-old startup developing a combination product for COPD, where she is the first Quality hire. In this episode Isha talks about the ten-year career plan she wrote overnight in 2005 after a hiring VP at Nektar asked what she wanted, and how it carried her from associate director to senior vice president. She explains why she moved to Boston in a blizzard to lead Quality at Ocular Therapeutix, a one-product company with two FDA complete response letters, and what she found in the inspection scribe notes. She walks through the reorganisation, letting go of people whose skill sets did not match the product classification, and the FDA inspection that ended in approval with no post-approval commitments. Isha also covers building Tenaya's Quality function, closing that same manufacturing facility four and a half years later, and choosing between consultants and permanent headcount. Topics covered: - Why a career plan written on paper beats a vague ambition - Reading the scribe notes, not just the CRL - Letting people go for skill fit, not performance - What FDA inspectors want to see when you are not finished - Green flags when a CEO hires their first head of Quality - Consultant or permanent hire: the two-year vision test - Why Quality is missing from early-stage boards - Quality as navigating grey zones, not yes or no Timestamps: (00:00) Introduction and guest background (02:52) Transitioning into Quality leadership (06:34) Career moves and a pivotal opportunity (08:38) A practical career plan (13:13) Turning around a Quality system (20:21) Building Quality in gene therapy (22:14) Choosing the right startup role (25:42) Building a lean Quality team (28:09) C-suite and board aspirations (30:10) Advice for aspiring Quality leaders

    Isha Patel on the Overnight Career Plan That Took Her from Associate Director to SVP
  4. Sep 1

    Dawn Houlihan on Her Journey From Ireland Big Pharma to the Boston Start-Up World

    Dawn Houlihan started out as the person manufacturing teams went quiet around, and spent the next twenty years proving that quality works better as a partner than a police force. Dawn Houlihan on Her Journey From Ireland Big Pharma to the Boston Start-Up World In today's episode I was joined by Dawn Houlihan. I wanted to speak to Dawn because she has built a quality function from nothing, and has done it across almost every stage and modality the industry has to offer. She spent half her career with Janssen in Ireland, moved to Scotland and then to Boston, and has since led quality through phase three, commercial approval and cell and gene therapy in two small companies where everything was outsourced. We talk about: What quality was actually like on the manufacturing floor in Ireland in the mid two thousandsThe mentor who told her to say yes to a project she did not have time forSwitching CDMO in the middle of phase three and still hitting commercial approvalWhy saying no to everything is the easy road, and what it costs a small companyBeing the first quality hire at Ensoma and building the culture from scratch Timestamps: (00:00) Introduction and Dawn's background in pharma (05:03) Quality's evolution: from policing to partnership (07:20) Mentorship, Scotland, and the move to Boston (13:10) Building quality teams in biotech startups (19:09) Trust, risk, and leading through partnership (29:29) Building quality from the ground up (34:16) The future of quality leadership and career advice

    Dawn Houlihan on Her Journey From Ireland Big Pharma to the Boston Start-Up World

Ratings & Reviews

5
out of 5
6 Ratings

About

“Let’s Talk Quality” is a podcast that seeks to shine a light on quality assurance, a profession that acts as the cornerstone for bringing safer medicine to patients. For life science companies to continue to develop life-saving medicines, a culture of good quality must be driven across the industry, whether that be an early phase gene therapy biotech or a global pharma organisation. This podcast aims to drive that mission forward through inviting industry leaders, experts, and visionaries to share their knowledge, experiences, and strategies for achieving quality excellence. Join us on a journey of discovery as we unravel the importance of quality and its profound impact on businesses and society. Get ready to engage in insightful discussions, gain valuable perspectives, and unlock the secrets to fostering a culture of quality in every aspect of life. Tune in and let’s embark on this exciting quality-driven adventure together.

You Might Also Like